Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Sep-24 6:16 PM View:  | Bicara Therapeutics Inc. (BCAX) | 17-Sep-24 | Conversion | 1,725,170 | -- | -- | 100% 0 to 1.73M | |
| 17-Sep-24 6:16 PM View: | Bicara Therapeutics Inc. (BCAX) | 17-Sep-24 | Private Purchase | 70,000 | $18.00 | $1,260,000.00 | 4% 1.73M to 1.8M | |
| 17-Jul-24 6:09 PM View: | Biomx Inc. (PHGE) | 15-Jul-24 | Option Exercise | 11,766,000 | -- | -- | 193% 6.11M to 17.88M | |
| 14-Jun-24 5:05 PM View: | Nuvalent, Inc. (NUVL) | 12-Jun-24 | Grant | 4,998 | -- | -- | < 1% 19.99M to 20.0M | |
| 19-Mar-24 9:39 PM View: | Biomx Inc. (PHGE) | 15-Mar-24 | Grant | 6,110,100 | -- | -- | 100% 0 to 6.11M | |
| 12-Mar-24 7:01 PM View: | Adapthealth Corp. (AHCO) | 12-Mar-24 | Sale | 114,906 | $10.70 | $1,229,490.00 | (< 1%) 13.37M to 13.26M | |
| 12-Mar-24 7:01 PM View: | Adapthealth Corp. (AHCO) | 11-Mar-24 | Sale | 182,607 | $11.02 | $2,012,560.00 | (1%) 13.56M to 13.37M | |
| 12-Mar-24 7:01 PM View: | Adapthealth Corp. (AHCO) | 08-Mar-24 | Sale | 52,487 | $10.93 | $573,652.00 | (< 1%) 13.61M to 13.56M | |
| 16-Feb-24 2:37 PM View: | Larimar Therapeutics, Inc. (LRMR) | 16-Feb-24 | Market Purchase | 4,290,620 | $8.74 | $37,500,000.00 | 25% 16.94M to 21.23M | 5% |
| 08-Feb-24 2:07 PM View: | Fractyl Health, Inc. (GUTS) | 06-Feb-24 | Conversion | 834,254 | -- | -- | 100% 0 to 834.25K | |
| 21-Nov-23 6:09 PM View: | Caremax, Inc. (CMAX) | 17-Nov-23 | Option Exercise Duplicate | 12,123 | -- | -- | < 1% 15.81M to 15.82M | |
| 30-Dec-22 7:16 PM View: | Oncorus, Inc. (ONCR) | 30-Dec-22 | Sale | 138,872 | $0.27 | $37,495.40 | (5%) 2.74M to 2.6M | |
| 30-Dec-22 7:16 PM View: | Oncorus, Inc. (ONCR) | 29-Dec-22 | Sale | 141,753 | $0.26 | $36,855.80 | (5%) 2.88M to 2.74M | |
| 30-Dec-22 7:16 PM View: | Oncorus, Inc. (ONCR) | 28-Dec-22 | Sale | 55,610 | $0.25 | $13,902.50 | (2%) 2.93M to 2.88M | |
| 27-Dec-22 6:33 PM View: | Oncorus, Inc. (ONCR) | 27-Dec-22 | Sale | 65,090 | $0.27 | $17,574.30 | (2%) 3.0M to 2.93M | |
| 27-Dec-22 6:33 PM View: | Oncorus, Inc. (ONCR) | 22-Dec-22 | Sale | 8,294 | $0.28 | $2,322.32 | (< 1%) 3.01M to 3.0M | |
| 21-Dec-22 7:09 PM View: | Oncorus, Inc. (ONCR) | 21-Dec-22 | Sale | 13,800 | $0.30 | $4,140.00 | (< 1%) 3.02M to 3.01M | |
| 21-Dec-22 7:09 PM View: | Oncorus, Inc. (ONCR) | 20-Dec-22 | Sale | 14,740 | $0.31 | $4,569.40 | (< 1%) 3.04M to 3.02M | |
| 21-Dec-22 7:09 PM View: | Oncorus, Inc. (ONCR) | 19-Dec-22 | Sale | 99,718 | $0.29 | $28,918.20 | (3%) 3.14M to 3.04M | |
| 15-Dec-22 6:50 PM View: | Oncorus, Inc. (ONCR) | 15-Dec-22 | Sale | 3,089 | $0.39 | $1,204.71 | (< 1%) 3.14M to 3.14M | |
| 15-Dec-22 6:50 PM View: | Oncorus, Inc. (ONCR) | 14-Dec-22 | Sale | 8,600 | $0.38 | $3,268.00 | (< 1%) 3.15M to 3.14M | |
| 15-Dec-22 6:50 PM View: | Oncorus, Inc. (ONCR) | 13-Dec-22 | Sale | 2,097 | $0.41 | $859.77 | (< 1%) 3.15M to 3.15M | |
| 07-Nov-22 6:24 PM View: | Nuvalent, Inc. (NUVL) | 03-Nov-22 | Purchase | 650,000 | $33.50 | $21,775,000.00 | 3% 19.34M to 19.99M | |
| 20-Sep-22 8:31 PM View: | Larimar Therapeutics, Inc. (LRMR) | 16-Sep-22 | Private Purchase | 11,111,100 | $3.15 | $35,000,000.00 | 191% 5.83M to 16.94M | |
| 08-Jun-22 7:25 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 06-Jun-22 | Private Sale | 38,478 | $25.01 | $962,256.00 | (1%) 3.28M to 3.24M | |
| 10-May-22 6:22 PM View: | Pepgen Inc. (PEPG) | 10-May-22 | Conversion | 536,960 | -- | -- | 100% 0 to 536.96K | |
| 10-May-22 6:22 PM View: | Pepgen Inc. (PEPG) | 10-May-22 | Purchase | 416,666 | $12.00 | $4,999,990.00 | 78% 536.96K to 953.63K | |
| 16-Nov-21 9:34 PM View: | Oncology Institute, Inc. (TOI) | 12-Nov-21 | Conversion | 85,153 | -- | -- | 3% 3.21M to 3.3M | |
| 28-Oct-21 7:15 PM View: | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 1,512,940 | -- | -- | 100% 0 to 1.51M | |
| 28-Oct-21 7:15 PM View: | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 775,000 | $16.00 | $12,400,000.00 | 51% 1.51M to 2.29M | |
| 04-Aug-21 6:05 PM View: | Nuvalent, Inc. (NUVL) | 02-Aug-21 | Conversion | 18,783,600 | -- | -- | 3370% 557.4K to 19.34M | |
| 21-Jul-21 5:14 PM View: | Acutus Medical, Inc. (AFIB) | 19-Jul-21 | Market Purchase | 1,071,430 | $14.00 | $15,000,000.00 | 25% 4.34M to 5.42M | (4%) |
| 13-Jul-21 12:06 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 09-Jul-21 | Market Sale | 99,325 | $15.81 | $1,570,330.00 | (3%) 3.38M to 3.28M | (5%) |
| 07-Jul-21 6:48 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 07-Jul-21 | Market Sale | 6,837 | $15.87 | $108,496.00 | (< 1%) 3.39M to 3.38M | (3%) |
| 07-Jul-21 6:48 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 06-Jul-21 | Market Sale | 49,239 | $16.19 | $797,426.00 | (1%) 3.44M to 3.39M | (< 1%) |
| 07-Jul-21 6:48 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 02-Jul-21 | Market Sale | 10,599 | $17.01 | $180,300.00 | (< 1%) 3.45M to 3.44M | 4% |
| 02-Jul-21 10:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 30-Jun-21 | Market Purchase | 685,710 | $8.75 | $5,999,960.00 | 13% 5.14M to 5.83M | 11% |
| 02-Sep-21 8:17 PM View: | Acutus Medical, Inc. (AFIB) | 17-Jun-21 | Grant Duplicate | 1,800 | -- | -- | 81% 2.22K to 4.02K | |
| 10-Jun-21 5:48 PM View: | Caremax, Inc. (CMAX) | 08-Jun-21 | Grant | 10,000,000 | $10.00 | $100,000,000.00 | 298% 3.36M to 13.36M | |
| 10-Jun-21 5:48 PM View: | Caremax, Inc. (CMAX) | 08-Jun-21 | Option Exercise | 3,418,750 | -- | -- | 26% 13.36M to 16.78M | |
| 03-Jun-21 5:04 PM View: | Singular Genomics Systems, ... (OMIC) | 01-Jun-21 | Conversion | 7,612,020 | $2.67 | $20,315,600.00 | 100% 0 to 7.61M | |
| 03-Jun-21 5:04 PM View: | Singular Genomics Systems, ... (OMIC) | 01-Jun-21 | Purchase | 1,500,000 | $22.00 | $33,000,000.00 | 20% 7.61M to 9.11M | |
| 04-May-21 12:34 PM View: | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 1,752,790 | -- | -- | 100% 0 to 1.75M | |
| 04-May-21 12:34 PM View: | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 800,000 | $16.00 | $12,800,000.00 | 46% 1.75M to 2.55M | |
| 30-Mar-21 3:42 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 30-Mar-21 | Conversion | 3,308,140 | -- | -- | 100% 0 to 3.31M | |
| 30-Mar-21 3:42 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 30-Mar-21 | Purchase Duplicate | 625,000 | $16.00 | $10,000,000.00 | 19% 3.31M to 3.93M | |
| 18-Feb-21 6:44 PM View: | Oncorus, Inc. (ONCR) | 17-Feb-21 | Market Purchase | 300,000 | $19.00 | $5,700,000.00 | 11% 2.85M to 3.15M | (11%) |
| 09-Feb-21 2:55 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 09-Feb-21 | Conversion | 1,717,030 | -- | -- | 100% 0 to 1.72M | |
| 09-Feb-21 2:55 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 09-Feb-21 | Purchase | 665,000 | $17.00 | $11,305,000.00 | 39% 1.72M to 2.38M | |
| 08-Jan-21 5:54 PM View: | Lumos Pharma, Inc. (LUMO) | 08-Jan-21 | Market Sale | 106,512 | $22.31 | $2,376,100.00 | (12%) 891.08K to 784.57K | (6%) |